# The Renal Protective Effects of Remote Ischemic Preconditioning in Patients With Chronic Kidney Disease

Study · id `cardio:ct-nct06501222` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06501222](<https://clinicaltrials.gov/study/NCT06501222>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06501222

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 114 participants.

## Technical summary

Registry record NCT06501222. Randomized; quadruple masking; primary purpose prevention. Start 2024-03-01 (actual); primary completion 2026-03-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 114 participants (planned count; ClinicalTrials.gov record NCT06501222, source copy `cardio:ctgov-nct06501222-2024-08-19`, retrieved 2026-10-26)
- Started: 2024-03-01 (actual) (ClinicalTrials.gov record NCT06501222, source copy `cardio:ctgov-nct06501222-2024-08-19`, retrieved 2026-10-26)
- Primary completion: 2026-03-30 (anticipated) (ClinicalTrials.gov record NCT06501222, source copy `cardio:ctgov-nct06501222-2024-08-19`, retrieved 2026-10-26)
- Completion: 2027-03-30 (anticipated) (ClinicalTrials.gov record NCT06501222, source copy `cardio:ctgov-nct06501222-2024-08-19`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06501222, source copy `cardio:ctgov-nct06501222-2024-08-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06501222-2024-08-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Renal Protective Effects of Remote Ischemic Preconditioning in Patients With Chronic Kidney Disease
- Condition: Chronic Kidney Diseases
- Intervention (Device): Remote ischemic conditioning
- Lead sponsor: Yuanjun Yang
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: d4b30f90eb06b86be1584453c1f31c9f3fa83dfa01bdf463eec13c35246dea5c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
